Emerging treatments for recurrent prostate cancer.

about

MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1.

P2860

Q38675837-63A3E9F5-692A-41AA-A60C-927C02E9D74F

P2860

Emerging treatments for recurrent prostate cancer.

Item

http://www.wikidata.org/entity/Q38599162

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Emerging treatments for recurrent prostate cancer.

@en

type

Item

label

Emerging treatments for recurrent prostate cancer.

@en

prefLabel

Emerging treatments for recurrent prostate cancer.

@en

P1476

Emerging treatments for recurrent prostate cancer.

@en

P2093

Catherine Hanna

http://www.w3.org/2001/XMLSchema#string

P2860

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Integrative clinical genomics of advanced prostate cancer.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Salvage focal prostate cryoablation for locally recurrent prostate cancer after radiotherapy: initial results from the cryo on-line data registry.

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer.

Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review.

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

P304

2873-2880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.15.228

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert J Jones

P577

2015-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26436556

http://www.w3.org/2001/XMLSchema#string

Emerging treatments for recurrent prostate cancer.

about

P2860

P2860

Emerging treatments for recurrent prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698